Recent Publications

 

• A Randomized, Double-Blind, Placebo-Controlled Trial of Oral Matricaria recutita (Chamomile) Extract Therapy for Generalized Anxiety Disorder
  
  
• A double-blind, placebo-controlled clinical trial of the safety and efficacy of the selegiline transdermal system without dietary restrictions in patients with major depression
  
  
• ADAM binding to serotonin transporters in patients with major depression and healthy controls: A preliminary study
  
  
• Brain imaging may show increased serotonin transporter availability in major depression
  
  
• Breast enlargement during chronic SSRI therapy
  
  
• Comparison of fluoxetine, olanzapine, and fluoxetine plus olanzapine in bipolar type I and bipolar type II major depression - Lack of manic induction
  
  
• Does tachyphylaxis occur after repeated antidepressant exposure in patients with bipolar II major depressive episode?
  
  
• Fluoxetine monotherapy for bipolar type II and bipolar NOS major depression
  
  
• Initial therapy of rapid and non-rapid cycling patients with bipolar II major depressive episode
  
  
• Initial therapy if rapid and non-rapid cycling patients with bipolar II major depressive episode
  
  
• MAOI safety and efficacy in advanced treatment-resistant depression
  
  
• Rates of flu-like infections in patients with affective illness
  
  
• Safety and efficacy of s-citalopram in patients with co-morbid major depression following successful treatment
  
  
• Safety and efficacy of s-citalopram in the treatment of co-morbid major depression and diabetes mellitus
  
  
• Selegiline transdermal system and the prevention of relapse of major depression disorder
  
  
• Short-term fluoxetine monotherapy for bipolar type II or bipolar NOS major depression - Low manic switch rate